Silvana Borges

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. ncbi Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment
    Silvana Borges
    Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, 46202, USA
    Clin Pharmacol Ther 80:61-74. 2006
  2. ncbi Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients
    Silvana Borges
    Division of Biostatistics Clinical Pharmacology, Indiana University, School of Medicine, 410 W 10th St, HITS 3000, Indianapolis, IN 46202 e mail
    J Clin Pharmacol 50:450-8. 2010
  3. ncbi A penalized mixture model approach in genotype/phenotype association analysis for quantitative phenotypes
    Lang Li
    Division of Biostatistics, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN
    Cancer Inform 9:93-103. 2010
  4. ncbi Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance
    Silvana Borges
    Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Drug Metab Dispos 33:1052-5. 2005

Detail Information

Publications4

  1. ncbi Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment
    Silvana Borges
    Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, 46202, USA
    Clin Pharmacol Ther 80:61-74. 2006
    ..We conducted a prospective trial in 158 patients with breast cancer who were taking tamoxifen to further understand the effect of CYP2D6 genotype and concomitant medications on endoxifen plasma concentrations...
  2. ncbi Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients
    Silvana Borges
    Division of Biostatistics Clinical Pharmacology, Indiana University, School of Medicine, 410 W 10th St, HITS 3000, Indianapolis, IN 46202 e mail
    J Clin Pharmacol 50:450-8. 2010
    ..However, endoxifen phenotypes still varied substantially, even with incorporation of CYD2D6 genotype and inhibiting factors, suggesting that other, as yet unidentified factors must be involved in tamoxifen activation...
  3. ncbi A penalized mixture model approach in genotype/phenotype association analysis for quantitative phenotypes
    Lang Li
    Division of Biostatistics, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN
    Cancer Inform 9:93-103. 2010
    ..The power and recovery rate of the true partition for the mixture model approach are investigated in statistical simulation studies, where it outperforms another published method...
  4. ncbi Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance
    Silvana Borges
    Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Drug Metab Dispos 33:1052-5. 2005
    ..Considering the required sample size and the low correlation with oral clearance, urinary metabolic ratio is not recommended as the primary outcome variable in studies requiring the detection of modest changes in CYP2D6 activity...